Outset Medical logo

Outset MedicalNASDAQ: OM

Profile

Sector:

Healthcare

Country:

United States

IPO:

15 September 2020

Next earnings report:

06 November 2024

Last dividends:

N/A

Next dividends:

N/A
$31.25 M
-98%vs. 3y high
29%vs. sector
-vs. 3y high
-vs. sector
-93%vs. 3y high
27%vs. sector
-99%vs. 3y high
8%vs. sector

Price

after hours | Fri, 01 Nov 2024 23:49:46 GMT
$0.60+$0.04(+7.14%)

Dividend

No data over the past 3 years
$27.39 M$26.90 M
$27.39 M-$34.45 M

Analysts recommendations

Institutional Ownership

OM Latest News

FINAL REMINDER OM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Outset Medical, Inc. Investors to Participate in the Class Action Lawsuit!
accesswire.com27 October 2024 Sentiment: NEGATIVE

NEW YORK CITY, NY / ACCESSWIRE / October 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company") (NASDAQ:OM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Outset Medical securities between September 15, 2020, and August 7, 2024, inclusive (the "Class Period").

OM DEADLINE: ROSEN, A RANKED AND LEADING FIRM, Encourages Outset Medical, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – OM
globenewswire.com25 October 2024 Sentiment: NEGATIVE

NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between September 15, 2020 and August 7, 2024, both dates inclusive (the “Class Period”), of the important October 28, 2024 lead plaintiff deadline.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM
prnewswire.com25 October 2024 Sentiment: NEGATIVE

NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outset Medical, Inc. (OM)
globenewswire.com24 October 2024 Sentiment: NEGATIVE

LOS ANGELES, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 28, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM ) securities between September 15, 2020 and August 7, 2024, inclusive (the “Class Period”).

Outset Medical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. Oct. 28, 2024 Deadline to file Lead Plaintiff Motion
globenewswire.com23 October 2024 Sentiment: NEGATIVE

Investors can contact the law firm at no cost to learn more about recovering their losses

OM LAWSUIT ALERT: Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
accesswire.com23 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109493&wire=1 or contact Joseph E. Levi, Esq.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Outset Medical Inc. On Behalf of Shareholders
accesswire.com23 October 2024 Sentiment: NEGATIVE

WILMINGTON, DE / ACCESSWIRE / October 23, 2024 / Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ GS:OM) on behalf of stockholders.

Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
globenewswire.com23 October 2024 Sentiment: POSITIVE

SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Wednesday, November 6, 2024.

Investors who lost money on Outset Medical, Inc.(OM) should contact Levi & Korsinsky about pending Class Action - OM
accesswire.com23 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 23, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109377&wire=1 or contact Joseph E. Levi, Esq.

OM Stockholders Have Opportunity to Lead Outset Medical, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accesswire.com23 October 2024 Sentiment: NEGATIVE

NEW YORK CITY, NY / ACCESSWIRE / October 23, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company") (NASDAQ:OM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Outset Medical securities between September 15, 2020, and August 7, 2024, inclusive (the "Class Period").

What type of business is Outset Medical?

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

What sector is Outset Medical in?

Outset Medical is in the Healthcare sector

What industry is Outset Medical in?

Outset Medical is in the Medical Devices industry

What country is Outset Medical from?

Outset Medical is headquartered in United States

When did Outset Medical go public?

Outset Medical initial public offering (IPO) was on 15 September 2020

What is Outset Medical website?

https://www.outsetmedical.com

Is Outset Medical in the S&P 500?

No, Outset Medical is not included in the S&P 500 index

Is Outset Medical in the NASDAQ 100?

No, Outset Medical is not included in the NASDAQ 100 index

Is Outset Medical in the Dow Jones?

No, Outset Medical is not included in the Dow Jones index

When was Outset Medical the previous earnings report?

No data

When does Outset Medical earnings report?

The next expected earnings date for Outset Medical is 06 November 2024